Literature DB >> 16164618

Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease.

Madhumathi Rao1, Brian J G Pereira.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16164618     DOI： 10.1111/j.1523-1755.2005.00554.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  12 in total

1.  Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia.

Authors:  Steven Fishbane; Geoffrey A Block; Lisa Loram; John Neylan; Pablo E Pergola; Katrin Uhlig; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2017-01-12       Impact factor: 10.121

2.  A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.

Authors:  Loreto Gesualdo; Gérard London; Matthew Turner; Christopher Lee; Karen Macdonald; David Goldsmith; Adrian Covic; Philippe Zaoui; Christian Combe; Johannes Mann; Frank Dellanna; Michael Muenzberg; Ivo Abraham
Journal:  Intern Emerg Med       Date:  2011-05-18       Impact factor: 3.397

3.  The prevalence and characteristics of anaemia at discharge home after intensive care.

Authors:  Timothy S Walsh; Ezz-el-din Saleh; Robert J Lee; D Brian McClelland
Journal:  Intensive Care Med       Date:  2006-06-02       Impact factor: 17.440

4.  Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.

Authors:  Ioannis Koulouridis; Mansour Alfayez; Thomas A Trikalinos; Ethan M Balk; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2012-08-22       Impact factor: 8.860

5.  Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients.

Authors:  Steven M Brunelli; Katherine E Lynch; Elizabeth D Ankers; Marshall M Joffe; Wei Yang; Ravi I Thadhani; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

6.  [Renal anemia - an important secondary disease in renal insufficiency].

Authors:  C Mayer; H Achenbach; M Stumvoll; G Fiedler
Journal:  Internist (Berl)       Date:  2006-03       Impact factor: 0.743

7.  Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.

Authors:  Nathalie Thilly; Bénédicte Stengel; Stéphanie Boini; Emmanuel Villar; Cécile Couchoud; Luc Frimat
Journal:  Nephron Clin Pract       Date:  2008-01-08

8.  Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study.

Authors:  Laura C Plantinga; Nancy E Fink; Bernard G Jaar; John H Sadler; Nathan W Levin; Josef Coresh; Michael J Klag; Neil R Powe
Journal:  BMC Health Serv Res       Date:  2007-01-09       Impact factor: 2.655

9.  Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations.

Authors:  Fernando Carrera; Michel Burnier
Journal:  NDT Plus       Date:  2009-01

10.  The Relation of Erythropoietin Towards Hemoglobin and Hematocrit in Varying Degrees of Renal Insufficiency.

Authors:  Mirsad Panjeta; Ismet Tahirovic; Jasenko Karamehic; Emin Sofic; Ognjen Ridic; Jozo Coric
Journal:  Mater Sociomed       Date:  2015-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.